Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Share News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Amryt Pharma chairman makes share purchase

Mon, 15th Mar 2021 16:38

(Sharecast News) - Amryt Pharma revealed on Monday that chairman Ram Stafford had acquired 300,100 ordinary shares in the AIM-listed commercial-stage biopharmaceutical company.
Stafford, who previously headed up Sudocrem owner Tosara Group, purchased the shares on Friday at an average price of 200.0p per share, for a total value of £600,200.

Last week, Amryt announced the signing of a distribution agreement with Medison Pharma to distribute its Myalepta product in Canada.

Amryt said the agreement completed its multi-regional distribution deals with Medison, first announced in February, to distribute Myalepta and Lojuxta in Israel and Juxtapid in Canada.

As of 1645 GMT, Amryt shares were up 3.54% at 205.0p.

Top Director Buys

Amryt Pharma (AMYT)
Director name: Stafford,Ray
Amount purchased: 300,100 @ 200.00p
Value: £600,200.00

Newriver Reit (NRR)
Director name: Lockhart,Allan
Amount purchased: 224,489 @ 97.58p
Value: £219,056.36

Newriver Reit (NRR)
Director name: Davies,Mark
Amount purchased: 185,000 @ 96.20p
Value: £177,970.00

Photo-me International (PHTM)
Director name: Crasnianski,Serge
Amount purchased: 282,029 @ 51.11p
Value: £144,145.02

Photo-me International (PHTM)
Director name: Crasnianski,Serge
Amount purchased: 250,000 @ 51.35p
Value: £128,374.99

Edinburgh Worldwide Inv Trust (EWI)
Director name: Wilson,Mungo
Amount purchased: 35,613 @ 350.50p
Value: £124,823.57

W Resources (WRES)
Director name: Masterman,Michael
Amount purchased: 95,000,000 @ 0.09p
Value: £86,402.50

Serco Group (SRP)
Director name: Lodge,Tim
Amount purchased: 40,000 @ 127.20p
Value: £50,880.00

Frenkel Topping Group (FEN)
Director name: Mills,Christopher
Amount purchased: 100,000 @ 45.00p
Value: £45,000.00

W Resources (WRES)
Director name: Masterman,Michael
Amount purchased: 37,000,000 @ 0.09p
Value: £31,524.00

F&c Investment Trust (FCIT)
Director name: Joy,Tom
Amount purchased: 3,500 @ 788.86p
Value: £27,610.10

W Resources (WRES)
Director name: Masterman,Michael
Amount purchased: 18,000,000 @ 0.09p
Value: £16,830.00

Lxi Reit (LXI)
Director name: Dimond,Patricia
Amount purchased: 8,005 @ 124.92p
Value: £9,999.53

Rockfire Resources (ROCK)
Director name: Walley,Nicholas
Amount purchased: 536,000 @ 0.95p
Value: £5,092.00

F&c Investment Trust (FCIT)
Director name: Ecsery,Francesca
Amount purchased: 380 @ 783.48p
Value: £2,977.24



Top Director Sells

Pagegroup (PAGE)
Director name: Ingham,Stephen
Amount sold: 41,638 @ 480.10p
Value: £199,904.04

Newriver Reit (NRR)
Director name: Davies,Mark
Amount sold: 185,000 @ 96.20p
Value: £177,970.00

Dukemount Capital (DKE)
Director name: Dart,Geoffrey
Amount sold: 27,000,000 @ 0.60p
Value: £162,000.00

Newriver Reit (NRR)
Director name: Lockhart,Allan
Amount sold: 133,745 @ 97.20p
Value: £130,000.14

Pagegroup (PAGE)
Director name: Stagg ,Kelvin
Amount sold: 20,774 @ 480.10p
Value: £99,735.98

Cropper (james) (CRPR)
Director name: Maddock,Isabelle
Amount sold: 500 @ 1,100.00p
Value: £5,500.00

More News
3 Jun 2020 11:52

UK TRADING UPDATE SUMMARY: Integumen Kicks Off Covid-19 Skin Trials

UK TRADING UPDATE SUMMARY: Integumen Kicks Off Covid-19 Skin Trials

Read more
11 May 2020 12:19

Amryt Pharma Cheers Strong 2019 And Beats Expectations So Far In 2020

Amryt Pharma Cheers Strong 2019 And Beats Expectations So Far In 2020

Read more
23 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

Read more
23 Mar 2020 19:01

Amryt Pharma Financially Strong, Revenue Rises More Double Digits

Amryt Pharma Financially Strong, Revenue Rises More Double Digits

Read more
19 Dec 2019 14:13

Amryt Pharma Shares Rise As It Cheers Aegerion Acquisition Synergies

Amryt Pharma Shares Rise As It Cheers Aegerion Acquisition Synergies

Read more
5 Nov 2019 11:09

Amryt Pharma upbeat on progress in first nine months of year

(Sharecast News) - Amryt Pharma updated the market on its trading update for the nine months ended 30 September on Tuesday, noting that it had completed the transaction to acquire Aegerion Pharmaceuticals on 24 September.

Read more
5 Nov 2019 10:23

Amryt Pharma Revenue Rises On Performance From Two New Assets

Amryt Pharma Revenue Rises On Performance From Two New Assets

Read more
1 Oct 2019 18:49

Amryt Pharma Skin Condition Drug Gets US FDA Fast Track Designation

Amryt Pharma Skin Condition Drug Gets US FDA Fast Track Designation

Read more
1 Oct 2019 15:08

Amryt gets FDA fast track for Oleogel-S10

(Sharecast News) - Biopharmaceutical company Amryt Pharma announced on Tuesday that the US Food and Drug Administration (FDA) has designated the investigation of 'AP101' - Oleogel-S10 - for the treatment of epidermolysis bullosa (EB) as a 'Fast Track' development programme.

Read more
30 Sep 2019 18:49

Amryt Pharma Loss Widens On Aegerion Deal Costs; Lojuxta Revenue Rises

Amryt Pharma Loss Widens On Aegerion Deal Costs; Lojuxta Revenue Rises

Read more
25 Sep 2019 12:24

Amryt Pharma Completes Combination With Aegerion Pharmaceuticals

Amryt Pharma Completes Combination With Aegerion Pharmaceuticals

Read more
24 Sep 2019 15:00

Amryt Pharma Shares Temporarily Suspended On Aegerion Buy

Amryt Pharma Shares Temporarily Suspended On Aegerion Buy

Read more
21 May 2019 12:35

Amryt Pharma Agrees To All-Paper Acquisition Of Aegerion (ALLISS)

LONDON (Alliance News) - Amryt Pharma PLC on Tuesday said it has agreed the all-paper acquisition of Aegerion Pharmaceuticals, a subsidiary of Novelion Therapeutics Inc, and intends to raise USD60

Read more
17 Apr 2019 11:17

Amryt Pharma Loss Narrows On Revenue From Cholesterol Drug Lojuxta

LONDON (Alliance News) - Amryt Pharma PLC on Wednesday said its annual loss narrowed as a result of increased revenue from its drug Lojuxta.The company's pretax loss shrank to EUR25.7

Read more
28 Feb 2019 14:39

Amryt gets approval to extend EASE trial to infants and children

(Sharecast News) - Orphan drug company Amryt Pharma updated the market on its phase 3 'EASE' trial for AP101 as a potential treatment for epidermolysis bullosa (EB) on Thursday, reporting that following an assessment by the trial's independent data monitoring committee, it could now enrol infants and children with EB between the ages of 21 days to four years in the trial.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.